CR20140151A
(en )
2014-05-26
PIPERIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES-1-ARILCARBOLINO-4-OXYA
BR112014006324A2
(en )
2016-06-07
method to treat hcv
CL2015001157A1
(en )
2015-10-16
Compositions and methods to treat proteinopathies.
BR112014018857A2
(en )
2017-06-20
nut
CO6791602A2
(en )
2013-11-14
Methods and systems for the treatment of wells
CO6811862A2
(en )
2013-12-16
Methods to treat multiple sclerosis and preserve and / or increase myelin content
BR112013033720A2
(en )
2016-08-16
method to treat eczema
CO6821964A2
(en )
2013-12-31
Compounds for the treatment of addiction
BR112013033944A2
(en )
2017-12-19
synergistic combination
BR112014006702A2
(en )
2017-06-13
method to treat osteoporosis
BR112013033974A2
(en )
2017-02-14
combination therapy
DK2760886T3
(en )
2019-12-09
Immunocytokin combination therapy
DK3395357T3
(en )
2019-08-19
COMPOSITION FOR CONTROLLED OVARI STIMULATION
BR112014009785A2
(en )
2017-04-25
method to treat or reduce efp
FI20115876A0
(en )
2011-09-06
Combination therapy
DK2697074T3
(en )
2019-09-02
SAFETY ACT
BR112013025299A2
(en )
2016-12-13
anchor set
DK2903896T3
(en )
2020-05-04
Course Facilities
BR112013008528A2
(en )
2019-09-24
Methods To Treat Psoriasis
CO6880064A2
(en )
2014-02-28
Therapeutic methods
BR112015015258A2
(en )
2017-09-26
Methods to Treat Gastrointestinal Tract Disorders
CO6821965A2
(en )
2013-12-31
Deuterated 1-piperazino-3-phenyl-indanes for the treatment of schizophrenia
DK3351554T3
(en )
2021-08-30
GLUTEN-RELATED DISORDERS
FI20115640A0
(en )
2011-06-22
combination therapy
FI20115288L
(en )
2012-09-26
I crushed